instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | AMIKACIN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DISULFIRAM, DOXYCYCLINE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endocarditis'. | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | CEFTRIAXONE, DISULFIRAM, DOXYCYCLINE | DrugsGivenReaction | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nocardia sepsis'. | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | CEFTRIAXONE, DISULFIRAM, DOXYCYCLINE | DrugsGivenReaction | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash maculo-papular'. | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | AMIKACIN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DISULFIRAM, DOXYCYCLINE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular device infection'. | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | CEFTRIAXONE, DISULFIRAM, DOXYCYCLINE | DrugsGivenReaction | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
What was the administration route of drug 'CEFTRIAXONE'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the administration route of drug 'DISULFIRAM'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
What was the dosage of drug 'AZITHROMYCIN ANHYDROUS'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | RECEIVED TWO 5DAYS COURSES OF AZITHROMYCIN | DrugDosageText | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the dosage of drug 'CEFTRIAXONE'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33728358 | 19,512,742 | 2021-03 |
What was the dosage of drug 'DISULFIRAM'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | HAD BEEN PRESCRIBED WITH INTERMITTENT COURSES | DrugDosageText | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the outcome of reaction 'Drug eruption'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovered | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the outcome of reaction 'Endocarditis bacterial'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovering | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the outcome of reaction 'Endocarditis'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovering | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
What was the outcome of reaction 'Nocardia sepsis'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovering | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
What was the outcome of reaction 'Nocardiosis'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovering | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the outcome of reaction 'Rash maculo-papular'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovered | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the outcome of reaction 'Septic pulmonary embolism'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovering | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
What was the outcome of reaction 'Vascular device infection'? | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | Recovering | ReactionOutcome | CC BY-NC-ND | 33728358 | 19,670,043 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States.
BACKGROUND
Multiple myeloma (MM) is the second most frequent hematologic malignancy after lymphoma, contributing to approximately 10% of all hematologic malignancies. The prognosis of patients with MM i... | CARFILZOMIB | DrugsGivenReaction | CC BY-NC | 33728584 | 19,735,371 | 2021-06 |
What was the outcome of reaction 'Death'? | Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States.
BACKGROUND
Multiple myeloma (MM) is the second most frequent hematologic malignancy after lymphoma, contributing to approximately 10% of all hematologic malignancies. The prognosis of patients with MM i... | Fatal | ReactionOutcome | CC BY-NC | 33728584 | 19,735,371 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute pulmonary oedema'. | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | NALOXONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33730013 | 19,165,260 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | NALOXONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33730013 | 19,165,260 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | NALOXONE | DrugsGivenReaction | CC BY-NC-ND | 33730013 | 19,082,994 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory distress'. | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | NALOXONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33730013 | 19,165,251 | 2021-03-17 |
What was the outcome of reaction 'Dyspnoea'? | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | Recovered | ReactionOutcome | CC BY-NC-ND | 33730013 | 19,165,260 | 2021-03-17 |
What was the outcome of reaction 'Mental disorder'? | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | Recovering | ReactionOutcome | CC BY-NC-ND | 33730013 | 19,082,994 | 2021-03-17 |
What was the outcome of reaction 'Respiratory distress'? | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | Recovering | ReactionOutcome | CC BY-NC-ND | 33730013 | 19,165,251 | 2021-03-17 |
What was the outcome of reaction 'Sinus tachycardia'? | Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series.
BACKGROUND Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effect... | Recovering | ReactionOutcome | CC BY-NC-ND | 33730013 | 19,082,994 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fall'. | Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.
BACKGROUND
Bone mineral density (BMD) declines when zoledronic acid (ZA) is administered. This case series describes the patterns of change in BMD when 1 or 2 doses of ZA are administered after denosumab.
METHODS
Twelve patient... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33730783 | 19,075,920 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radius fracture'. | Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.
BACKGROUND
Bone mineral density (BMD) declines when zoledronic acid (ZA) is administered. This case series describes the patterns of change in BMD when 1 or 2 doses of ZA are administered after denosumab.
METHODS
Twelve patient... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33730783 | 19,075,920 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.
BACKGROUND
Bone mineral density (BMD) declines when zoledronic acid (ZA) is administered. This case series describes the patterns of change in BMD when 1 or 2 doses of ZA are administered after denosumab.
METHODS
Twelve patient... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33730783 | 19,075,920 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wrist fracture'. | Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.
BACKGROUND
Bone mineral density (BMD) declines when zoledronic acid (ZA) is administered. This case series describes the patterns of change in BMD when 1 or 2 doses of ZA are administered after denosumab.
METHODS
Twelve patient... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33730783 | 19,281,652 | 2021-02 |
What was the dosage of drug 'DENOSUMAB'? | Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.
BACKGROUND
Bone mineral density (BMD) declines when zoledronic acid (ZA) is administered. This case series describes the patterns of change in BMD when 1 or 2 doses of ZA are administered after denosumab.
METHODS
Twelve patient... | UNKNOWN | DrugDosageText | CC BY-NC | 33730783 | 19,281,652 | 2021-02 |
What was the dosage of drug 'ZOLEDRONIC ACID'? | Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.
BACKGROUND
Bone mineral density (BMD) declines when zoledronic acid (ZA) is administered. This case series describes the patterns of change in BMD when 1 or 2 doses of ZA are administered after denosumab.
METHODS
Twelve patient... | UNKNOWN | DrugDosageText | CC BY-NC | 33730783 | 19,281,652 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Steroid diabetes'. | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | Oral | DrugAdministrationRoute | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | 1.6 MG/KG, DAILY | DrugDosageText | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | 1.6 MG/KG, 1X/DAY | DrugDosageText | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
What was the outcome of reaction 'Drug ineffective'? | Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We inves... | Recovered | ReactionOutcome | CC BY | 33731004 | 19,866,414 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infective aneurysm'. | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | DrugsGivenReaction | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mycobacterial infection'. | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | DrugsGivenReaction | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular graft infection'. | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | DrugsGivenReaction | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
What was the administration route of drug 'BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN'? | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | Intravesical | DrugAdministrationRoute | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
What was the dosage of drug 'BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN'? | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | MULTIPLE APLLICATIONS | DrugDosageText | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
What was the outcome of reaction 'Infective aneurysm'? | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | Recovered | ReactionOutcome | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
What was the outcome of reaction 'Mycobacterial infection'? | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | Recovered | ReactionOutcome | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
What was the outcome of reaction 'Vascular graft infection'? | Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
BACKGROUND
So called "mycotic" aortic aneurysms account for only 0.7 to 1.3% of all aortic aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species. Bacill... | Recovered | ReactionOutcome | CC BY | 33731071 | 19,110,873 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. ... | BORTEZOMIB, DEXAMETHASONE, POMALIDOMIDE | DrugsGivenReaction | CC BY | 33731690 | 20,634,941 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to central nervous system'. | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. ... | CARFILZOMIB, CYCLOPHOSPHAMIDE, DARATUMUMAB, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY | 33731690 | 19,386,747 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. ... | CARFILZOMIB, CYCLOPHOSPHAMIDE, DARATUMUMAB, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY | 33731690 | 19,386,747 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma recurrent'. | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. ... | CARFILZOMIB, CYCLOPHOSPHAMIDE, DARATUMUMAB, DEXAMETHASONE, LENALIDOMIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY | 33731690 | 19,386,747 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. ... | BORTEZOMIB, CISPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, POMALIDOMIDE | DrugsGivenReaction | CC BY | 33731690 | 19,443,402 | 2021-03-17 |
What was the outcome of reaction 'Metastases to central nervous system'? | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. ... | Recovering | ReactionOutcome | CC BY | 33731690 | 19,386,747 | 2021-03-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Urachal carcinoma revealed by isolated hematuria.
Urachal carcinoma is an aggressive and rare neoplasia of bladder cancer involving the urachus. The diagnostic failure is due to its insidious development as well as its non-specific clinical signs. Management constitutes a real dilemma for urological surgeons. We descri... | FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33732451 | 19,185,715 | 2021-03 |
What was the dosage of drug 'FLUOROURACIL'? | Urachal carcinoma revealed by isolated hematuria.
Urachal carcinoma is an aggressive and rare neoplasia of bladder cancer involving the urachus. The diagnostic failure is due to its insidious development as well as its non-specific clinical signs. Management constitutes a real dilemma for urological surgeons. We descri... | 3 CYCLIC | DrugDosageText | CC BY | 33732451 | 19,185,715 | 2021-03 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Urachal carcinoma revealed by isolated hematuria.
Urachal carcinoma is an aggressive and rare neoplasia of bladder cancer involving the urachus. The diagnostic failure is due to its insidious development as well as its non-specific clinical signs. Management constitutes a real dilemma for urological surgeons. We descri... | 3 CYCLIC | DrugDosageText | CC BY | 33732451 | 19,185,715 | 2021-03 |
What was the dosage of drug 'OXALIPLATIN'? | Urachal carcinoma revealed by isolated hematuria.
Urachal carcinoma is an aggressive and rare neoplasia of bladder cancer involving the urachus. The diagnostic failure is due to its insidious development as well as its non-specific clinical signs. Management constitutes a real dilemma for urological surgeons. We descri... | 3 CYCLIC | DrugDosageText | CC BY | 33732451 | 19,185,715 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Compression fracture'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | SUNITINIB, TEMSIROLIMUS, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | SUNITINIB, TEMSIROLIMUS, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphonia'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver disorder'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | SUNITINIB, TEMSIROLIMUS, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | SUNITINIB, TEMSIROLIMUS, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | SUNITINIB, TEMSIROLIMUS, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | AXITINIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33732457 | 19,122,950 | 2021-04 |
What was the outcome of reaction 'Liver disorder'? | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
What was the outcome of reaction 'Malaise'? | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
What was the outcome of reaction 'Pyrexia'? | Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
A 46-year-old man underwent right partial nephrectomy for type 2 papillary renal cell carcinoma (PRCC) in 2011. Lung metastasis and lymph node (LN) metastases around the inf... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732457 | 19,952,254 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory distress syndrome'. | Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.
Cytokine release syndrome (CRS) is known to be associated with severe coronavirus disease 2019 (COVID-19). Multiple anti-inflammatory therapies such as tocilizumab, cor... | DARUNAVIR\RITONAVIR, FAVIPIRAVIR, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33732466 | 19,181,917 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.
Cytokine release syndrome (CRS) is known to be associated with severe coronavirus disease 2019 (COVID-19). Multiple anti-inflammatory therapies such as tocilizumab, cor... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, FAVIPIRAVIR, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33732466 | 19,181,918 | 2021-04 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.
Cytokine release syndrome (CRS) is known to be associated with severe coronavirus disease 2019 (COVID-19). Multiple anti-inflammatory therapies such as tocilizumab, cor... | Recovered | ReactionOutcome | CC BY | 33732466 | 19,181,917 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood electrolytes abnormal'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cryptosporidiosis infection'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus oesophagitis'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | ATAZANAVIR\RITONAVIR, AZITHROMYCIN, DAPSONE, EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE, FLUCONAZOLE, LAMIVUDINE, NITAZOXANIDE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrolyte imbalance'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | ATAZANAVIR\RITONAVIR, AZITHROMYCIN, DAPSONE, EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE, FLUCONAZOLE, LAMIVUDINE, NITAZOXANIDE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal candidiasis'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oral mucosal erythema'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Punctate keratitis'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'SJS-TEN overlap'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin lesion'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stevens-Johnson syndrome'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC | 33732476 | 20,020,604 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | DAPSONE, EFAVIRENZ, FLUCONAZOLE, LAMIVUDINE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic epidermal necrolysis'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC | 33732476 | 20,020,604 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | ATAZANAVIR\RITONAVIR, AZITHROMYCIN, DAPSONE, EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE, FLUCONAZOLE, LAMIVUDINE, NITAZOXANIDE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33732476 | 20,020,604 | 2021-03 |
What was the dosage of drug 'ATAZANAVIR\RITONAVIR'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | UNK, SECOND-LINE THERAPY | DrugDosageText | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
What was the dosage of drug 'AZITHROMYCIN'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | UNK, QD (ONCE DAILY) | DrugDosageText | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
What was the dosage of drug 'EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | UNK, FIRST-LINE THERAPY | DrugDosageText | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
What was the dosage of drug 'LAMIVUDINE'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | UNK, SECOND-LINE THERAPY | DrugDosageText | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.